Michael Greenwood

Michael Greenwood

Feature Writer

B.Sc. Chemistry, M.Sc. Drug Design and Discovery

Michael graduated from the University of Salford with a PhD in Biochemistry in 2023, and has keen research interests towards nanotechnology and its application to biological systems. Michael has written on a wide range of science communication and news topics within the life sciences and related fields since 2019, and engages extensively with current developments in journal publications.  

Articles from Michael

Developing a COVID-19 vaccine using inactivated E. coli

Developing a COVID-19 vaccine using inactivated E. coli

Human Tumor Xenograft Models

Human Tumor Xenograft Models

Identifying druggable targets on an essential SARS-CoV-2 protein

Identifying druggable targets on an essential SARS-CoV-2 protein

What is Quantitative Systems Pharmacology (QSP) Modeling?

What is Quantitative Systems Pharmacology (QSP) Modeling?

Vaccinating the elderly first for COVID-19 saves most lives

Vaccinating the elderly first for COVID-19 saves most lives

What are RNA Therapeutics?

What are RNA Therapeutics?

Metastudy of pregnant women reveals risk factors for COVID-19

Metastudy of pregnant women reveals risk factors for COVID-19

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Genetic variation associated with COVID-19 outcome

Genetic variation associated with COVID-19 outcome

A backbone free energy study of SARS-CoV-2 variants of concern

A backbone free energy study of SARS-CoV-2 variants of concern

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.